Lamina Propria Phagocyte Profiling Reveals Targetable Signaling Pathways in Refractory Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

Lamina Propria Phagocyte Profiling Reveals Targetable Signaling Pathways in Refractory Inflammatory Bowel Disease

Published:2022 Issue:3 Volume:1 Page:380-392
ISSN:2772-5723
Container-title:Gastro Hep Advances
language:en
Short-container-title:Gastro Hep Advances

Author:

Jacobsen Gillian E.,Fernández Irina,Quintero Maria A.,Santander Ana M.,Pignac-Kobinger Judith,Damas Oriana M.,Deshpande Amar R.,Kerman David H.,Ban Yuguang,Gao Zhen,Silva Tiago C.,Wang Lily,Beecham Ashley H.,McCauley Jacob L.,Burgueño Juan F.,Abreu Maria T.^ORCID

Publisher

Elsevier BV

Reference64 articles.

1. Inflammatory bowel disease is presenting sooner after immigration in more recent US immigrants from Cuba;Damas;Aliment Pharmacol Ther,2017

2. Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD;Na;Nat Rev Gastroenterol Hepatol,2019

3. Bacterial translocation as inflammatory driver in Crohn's disease;Linares;Front Cell Dev Biol,2021

4. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease;de Lange;Nat Genet,2017

5. Targeting immune cell circuits and trafficking in inflammatory bowel disease;Neurath;Nat Immunol,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stromal-Like Cells Are Found in Peripheral Blood of Patients With Inflammatory Bowel Disease and Correlate With Immune Activation State;Clinical and Translational Gastroenterology;2024-06-01

2. Upadacitinib in Crohn’s disease: needs more insight;Expert Opinion on Pharmacotherapy;2024-05-23

3. Tofacitinib Versus Oral Prednisolone for Induction of Remission in Moderately Active Ulcerative Colitis [ORCHID]: A Prospective, Open-Label, Randomized, Pilot Study;Journal of Crohn's and Colitis;2023-09-01

4. JAK1 Inhibition to Treat Crohn’s Disease;New England Journal of Medicine;2023-05-25

5. Personalizing therapy selection in inflammatory bowel disease;Expert Review of Clinical Immunology;2023-04-03